The Boston University Ryan Center for Sports Medicine and Related Services and Seqster (San Diego, California) plan to partner in the Ryan Center’s proof of concept study for identifying potential digital biomarkers of traumatic brain injury (TBI) in concussed patients, potentially improving clinical diagnosis and treatment of head injury. The Ryan Center offers support and evidence-based care for concussion, TBI, and other injuries related to physical activity whether from personal training, recreational sport, or organized athletics. Athletes from Boston University, Boston College, Boston Public Schools, and USAGymnastics are treated at the Ryan Center, as are those referred from the Boston Medical Center and the greater Boston area community.
The Ryan Center will use Seqster’s health-data platform to recruit participants with and without concussion who are seeking care at the Ryan Center. Digital health metrics being assessed in the study will be tracked using this platform. Seqster’s platform aggregates patient data from multiple sources, allowing more longitudinal health data to be incorporated into research studies. Patients who use the Seqster platform control all of their own available health information including electronic health records, data from wearable technology and apps, ancestry, and genomics, while providing control over and full transparency for data usage.
"With our unique consumer-centric platform, we have created the Seqster Research Portal which allows any academic or pharmaceutical clinical trial to rapidly enroll participants into their study and aggregate all available health data directly from the source," said Ardy Arianpour, CEO and co-founder, Seqster. "We are proud that Boston University Ryan Center and Dr. Rhoda Au selected Seqster to be their digital health platform that will advance the study and care of brain injury patients."
"Seqster rapidly aggregates patient data from multiple data sources, which has the ability to enrich existing studies with more longitudinal personal health data and almost instantly populate de novo cohorts with longitudinal clinical data," said Rhoda Au, Ph.D, Principal Investigator for the study and Professor of Anatomy & Neurobiology, Neurology and Epidemiology at Boston University Schools of Medicine and Public Health. "Since being introduced to Seqster's technology in January, we have moved quickly to incorporate their platform into this study and a number of other studies that are in the planning stages. We are excited to be able to leverage the power of Seqster's platform to get meaningful results faster starting with this important study."Next Story